Mouwasat Medical Services Company (TADAWUL:4002)
65.50
+0.20 (0.31%)
Sep 3, 2026, 3:19 PM AST
TADAWUL:4002 Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, TADAWUL:4002 stock has a consensus rating of "Buy" and an average price target of SAR 82.62. The average 1-year stock price forecast is 26.14% higher than the current stock price, while the lowest is SAR 63.00 (-3.82%) and the highest is SAR 106.00 (+61.83%).
Price Target: SAR 82.62 (+26.14%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for TADAWUL:4002 stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 5 | 5 | 6 | 6 | 6 |
| Buy | 1 | 1 | 0 | 1 | 1 | 1 |
| Hold | 6 | 5 | 6 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 1 | 1 | 0 | 0 | 0 |
| Total | 10 | 12 | 12 | 12 | 12 | 12 |
Financial Forecast
Revenue This Year
3.60B
from 3.22B
Increased by 11.73%
Revenue Next Year
3.96B
from 3.60B
Increased by 9.96%
EPS This Year
4.27
from 4.11
Increased by 3.97%
EPS Next Year
4.45
from 4.27
Increased by 4.05%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SAR.